Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Palatability of Benzydamine HCl Lozenges
NCT07199543Phase 1Completed
- Sponsor
- Angelini Pharma
- Start
- Apr 2025
- Primary completion
- Jul 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of benzydamine in pharyngitis (2 arms), sponsored by Angelini Pharma. Primary endpoint: Palatability of a new flavour. Started Apr 2025; status: completed.
02
Drugs
benzydamine
03
Conditions
pharyngitis
Beyond the preview
Go deeper on NCT07199543.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07199543.